Antiretroviral therapy coverage in Latvia
Latvia: Antiretroviral therapy coverage was 52.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage in Latvia, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
Latvia recorded 52.0% for antiretroviral therapy coverage in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 2.0% on the previous year and up 271.4% over ten years.
Over the whole period, antiretroviral therapy coverage in Latvia peaked at 52.0% in 2024 and was at its lowest, 1.0%, in 2000.
Latvia ranks 117th of 143 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage in Latvia, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 1.0% | — |
| 2001 | 1.0% | +0.0% |
| 2002 | 1.0% | +0.0% |
| 2003 | 2.0% | +100.0% |
| 2004 | 2.0% | +0.0% |
| 2005 | 2.0% | +0.0% |
| 2006 | 3.0% | +50.0% |
| 2007 | 6.0% | +100.0% |
| 2008 | 6.0% | +0.0% |
| 2009 | 8.0% | +33.3% |
| 2010 | 9.0% | +12.5% |
| 2011 | 10.0% | +11.1% |
| 2012 | 11.0% | +10.0% |
| 2013 | 13.0% | +18.2% |
| 2014 | 14.0% | +7.7% |
| 2015 | 15.0% | +7.1% |
| 2016 | 28.0% | +86.7% |
| 2017 | 34.0% | +21.4% |
| 2018 | 40.0% | +17.6% |
| 2019 | 46.0% | +15.0% |
| 2020 | 47.0% | +2.2% |
| 2021 | 49.0% | +4.3% |
| 2022 | 50.0% | +2.0% |
| 2023 | 51.0% | +2.0% |
| 2024 | 52.0% | +2.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.2% | 1.0% | 8.0% | 10 |
| 2010s | 22.0% | 9.0% | 46.0% | 10 |
| 2020s | 49.8% | 47.0% | 52.0% | 5 |
Countries ranked near Latvia
More health data for Latvia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3876 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,593 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -6.17 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0202 units per person (2025)
- Population ages 00-04, male, annual growth rate -6.02 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Latvia?
- Antiretroviral therapy coverage in Latvia was 52.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Latvia?
- The highest recorded value was 52.0% in 2024.
- What is the lowest antiretroviral therapy coverage recorded in Latvia?
- The lowest recorded value was 1.0% in 2000.
- How does Latvia rank for antiretroviral therapy coverage?
- Latvia ranks 117th out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Latvia?
- Over the last ten years it is up 271.4%. The long-run trend across the full record is volatile.
- Where does this Latvia data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.